Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S, Sabatos-Peyton C, Petruzzelli L, Engelman JA, Dranoff G (2017) Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer 17(5):286–301. https://doi.org/10.1038/nrc.2017.17

Article  CAS  PubMed  Google Scholar 

Roy R, Singh SK, Misra S (2022) Advancements in cancer immunotherapies. Vaccines (Basel) 11:1. https://doi.org/10.3390/vaccines11010059

Article  CAS  Google Scholar 

Johnson DB, Nebhan CA, Moslehi JJ, Balko JM (2022) Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol 19(4):254–267. https://doi.org/10.1038/s41571-022-00600-w

Article  PubMed  PubMed Central  Google Scholar 

Postow MA, Sidlow R, Hellmann MD (2018) Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378(2):158–168. https://doi.org/10.1056/NEJMra1703481

Article  CAS  PubMed  Google Scholar 

Zhou X, Yao Z, Bai H, Duan J, Wang Z, Wang X, Zhang X, Xu J, Fei K, Zhang Z, Tan F, Xue Q, Gao S, Gao Y, Wang J, He J (2021) Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis. Lancet Oncol 22(9):1265–1274. https://doi.org/10.1016/s1470-2045(21)00333-8

Article  CAS  PubMed  Google Scholar 

Abdel-Rahman O, Helbling D, Schmidt J, Petrausch U, Giryes A, Mehrabi A, Schöb O, Mannhart M, Zidan A, Oweira H (2016) Treatment-associated fatigue in cancer patients treated with immune checkpoint inhibitors; a systematic review and meta-analysis. Clin Oncol (R Coll Radiol) 28(10):e127-138. https://doi.org/10.1016/j.clon.2016.06.008

Article  CAS  PubMed  Google Scholar 

Kiss I, Kuhn M, Hrusak K, Buchler T (2022) Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis. ESMO Open 7(3):100474. https://doi.org/10.1016/j.esmoop.2022.100474

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24(6):547–561. https://doi.org/10.1016/s0885-3924(02)00529-8

Article  PubMed  Google Scholar 

Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528–538. https://doi.org/10.1002/cncr.10245

Article  PubMed  Google Scholar 

Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63–74. https://doi.org/10.1016/s0885-3924(96)00274-6

Article  CAS  PubMed  Google Scholar 

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579. https://doi.org/10.1200/jco.1993.11.3.570

Article  CAS  PubMed  Google Scholar 

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

Article  CAS  PubMed  Google Scholar 

Vodermaier A, Millman RD (2011) Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19:1899–1908. https://doi.org/10.1007/s00520-011-1251-4

Article  PubMed  Google Scholar 

Rodgers J, Martin C, Morse R, Kendell K, Verrill M (2005) An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer. Health Qual Life Outcomes 3:41

Article  PubMed  PubMed Central  Google Scholar 

Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9

Article  CAS  PubMed  Google Scholar 

Cheung WY, Barmala N, Zarinehbaf S, Rodin G, Le LW, Zimmermann C (2009) The Association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage 37(3):297–304. https://doi.org/10.1016/j.jpainsymman.2008.03.008

Article  PubMed  Google Scholar 

Bruera EKN, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6

Article  CAS  PubMed  Google Scholar 

Richardson LA, Jones GW (2009) A review of the reliability and validity of the edmonton symptom assessment system. Curr Oncol (Toronto, Ont) 16(1):55

CAS  Google Scholar 

Donovan KA, Stein KD, Lee M, Leach CR, Ilozumba O, Jacobsen PB (2015) Systematic review of the multidimensional fatigue symptom inventory-short form. Support Care Cancer 23(1):191–212. https://doi.org/10.1007/s00520-014-2389-7

Article  PubMed  Google Scholar 

Stein KD, Jacobsen PB, Blanchard CM, Thors C (2004) Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 27(1):14–23. https://doi.org/10.1016/j.jpainsymman.2003.06.003

Article  PubMed  PubMed Central  Google Scholar 

Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194. https://doi.org/10.1016/j.jclinepi.2010.04.011

Article  PubMed  PubMed Central  Google Scholar 

Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S (1997) The Memorial Delirium Assessment Scale. J Pain Symptom Manage 13(3):128–137. https://doi.org/10.1016/s0885-3924(96)00316-8

Article  CAS  PubMed  Google Scholar 

Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S (2007) The memorial delirium assessment scale. J Pain Symptom Manage 13:128–137

Article  Google Scholar 

Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, Ladwa R, O’Byrne K, Kulasinghe A (2022) Immune checkpoint inhibitors in cancer therapy. Curr Oncol 29(5):3044–3060. https://doi.org/10.3390/curroncol29050247

Article  PubMed  PubMed Central  Google Scholar 

Cortellini A, Vitale MG, De Galitiis F et al (2019) Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice. J Transl Med 17(1):376

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJM, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8):711–723. https://doi.org/10.1056/NEJMoa1003466

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jim HSL, Eisel SL, Hoogland AI, Shaw S, King JC, Dicker AP (2021) Use of a cancer registry to evaluate patient-reported outcomes of immune checkpoint inhibitors. Cancers 13(1):103

Article  CAS  Google Scholar 

Miaskowski C, Paul SM, Cooper BA, et al. (2008) Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. J pain and symptom manage 35(6):632–643. PMC2491660

Truong PT, Berthelet E, Lee JC et al (2006) Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. Can J Urol 13(3):3139–3146

PubMed